213327-37-8
213327-37-8
Chemical Structure
Oregovomab
Synonym(s): Alt-2 monoclonal antibody; MAB-B43.13; Oregovamab
- CAS No.: 213327-37-8
- Formula:N/A
- Molecular Weight:(146.72 kDa)
IUPAC Name: 1-chloro-3-(difluoromethyl)-2-ethylbenzene
SMILES: [Oregovomab]
Biological Activity: Oregovomab (Alt-2 monoclonal antibody) is a murine mAb targeting CA125. Oregovomab induces cytotoxic immune response against CA125 expressing tumor cells[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oregovomab | 99.66% | Oregovomab (Alt-2 monoclonal antibody) is a murine mAb targeting CA125. Oregovomab induces cytotoxic immune response against CA125 expressing tumor cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Pietragalla A, et al. Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opin Investig Drugs. 2021 Feb;30(2):103-110. [Content Brief]
- [2]. Sparholt MH, et al. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? APMIS. 2013 Jan;121(1):38-44. [Content Brief]
